Trials / Completed
CompletedNCT02186652
PK Study With Pantoprazole in Obese Children and Adolescents
The Effect of Obesity on the Pharmacokinetics of Pantoprazole in Children and Adolescents
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Phillip Brian Smith · Academic / Other
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, comparative single-dose pharmacokinetic (PK) study
Detailed description
Evaluate the pharmacokinetics of pantoprazole in obese children and adolescents with gastroesophageal reflux disease (GERD) following administration of an oral dose of pantoprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole |
Timeline
- Start date
- 2014-06-04
- Primary completion
- 2015-09-13
- Completion
- 2015-09-13
- First posted
- 2014-07-10
- Last updated
- 2019-09-17
- Results posted
- 2019-08-05
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02186652. Inclusion in this directory is not an endorsement.